Integrating molecular docking and network pharmacology to reveal the molecular mechanisms of Anemarrhena asphodeloides in the treatment of non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s12672-025-03178-8
Published Online: 2025-07-24
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xie, Xianshun
Jiang, Yiling
Liu, Sumei
Xie, Changjun
Text and Data Mining valid from 2025-07-24
Version of Record valid from 2025-07-24
Article History
Received: 22 January 2025
Accepted: 7 April 2025
First Online: 24 July 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.